HPV/HBV or HPV/HCV Co-Infections in Women Treated for Chronic Hepatitis at Hôpital Saint Camille in Ouagadougou, Burkina Faso,
Auteur(s): OUÉDRAOGO Estelle, ZOHONCON Théodora Mahoukèdè, BAYALA Bagora, BADO Prosper, DA Rose P Clémence, OUEDRAOGO Rogomenoma Alice, TRAORÉ Ina Marie Angèle, KUASSI-KPEDE Punya Akouélé, OUÉDRAOGO Samiratou, DOVO Essi Etonam, TRAORÉ Lassina, YONLI Albert Théophane, DJIGMA Florencia Wendkuuni, LOMPO Olga Mélanie, SIMPORE Jacques
Auteur(s) tagués: Samiratou OUEDRAOGO ;
Résumé

Introduction
Cervical cancer is a public health concern and is mainly caused by Human papillomaviruses (HPV). In many parts of the world, studies are being carried out to understand the different genotypes to better tackle this issue. We conducted a study to determine the prevalence of HPV genotypes in women with chronic hepatitis B or C infection, co-infected or not with HIV, treated at the Hôpital Saint Camille in Ouagadougou (Burkina Faso).
Methods
This study was conducted from April to July 2023, including 100 women in gastroenterology at Hôpital Saint Camille. A questionnaire on their socio-demographic and life style was administrated; and endocervical samples were collected using sterile swabs and then sent to Centre of Biomolecular Research Pietro Annigoni (CERBA). HPV molecular detection and genotyping were performed by PCR and hybridization using the HPV Direct Flow Chips kit. Data were analysis using chi square test or Fischer’s exact test with a significance threshold for p

Mots-clés

962
Enseignants
5577
Publications
49
Laboratoires
84
Projets